✦ LIBER ✦

Efalizumab retreatment in patients with moderate to severe chronic plaque psoriasis

✍ Scribed by Kim A. Papp; Bruce Miller; Kenneth B. Gordon; Ivor Caro; Paul Kwon; Peter G. Compton; Craig L. Leonardi

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and efficacy of efalizumab therap

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Safety of Efalizumab in Patients with Mo

✍ Kim A. Papp; Charles Camisa; Stephen P. Stone; Ivor Caro; Xiaolin Wang; Peter Co 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 139 KB

Long-term efficacy of up to 15 months’ e

✍ Darryl P. Toth; Kim Papp; David Gratton 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 380 KB

Safety events in moderate to severe psor

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Long-term continuous efalizumab therapy

✍ Alice B. Gottlieb; Tiffani Hamilton; Ivor Caro; Paul Kwon; Peter G. Compton; Cra 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 298 KB

The safety of efalizumab in patients wit

✍ Craig Leonardi; Bernard Goffe; Jeff Sobell; Ivor Caro 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 59 KB